IPSC

1.16511.74%
BP

Brent Pfeiffenberger

President, CEO & Chairman

Dr. Brent Pfeiffenberger, Pharm.D., MBA, has been Chief Executive Officer, President and Director of Century Therapeutics, Inc. since December 04, 2023 and serves as its Chairman since August 14, 2025. He serves as Director at Corbus Pharmaceuticals Holdings, Inc. from May 2026. He served as Chief Operating Officer at Neogene Therapeutics, Inc. since June 2021. He had been a Director of Bristol-Myers Squibb Australia Pty Ltd since April 15, 2016. He was Co-Lead of Worldwide Commercial Oncology from July 2018 until October 2019; General Manager for Australia and New Zealand from March 2016 until June 2018. He has extensive experience from both general operational management and commercial leadership roles. He held several critical business leadership roles both within and outside the U.S at Bristol Myers Squibb and most recently he served as senior vice president, head of U.S. Oncology, where he oversaw an extensive oncology portfolio. He received an M.B.A. from The Wharton School at the University of Pennsylvania and a Pharm.D. from Duquesne University.

Positions